Most of the therapies listed were identified by the MS Society as relevant, others were added based on Gregory’s findings.

In each section we list the published articles and any clinical trials that include the new drug in the title. In cases where the relevancy of the new drug didn’t come from the MS Society, we also mention it in the page.s

December 25, 2021

Alemtuzumab

Read more

December 14, 2021

Natalizumab

Read more

by ,

October 26, 2021

Covid-19

Read more

by ,

October 15, 2021

aHSCT

Read more

by ,

August 31, 2021

Tolebrutinib

Read more

August 17, 2021

Cladribine

Read more

August 14, 2021

Simvastatin

Read more

August 14, 2021

Tcelna

Read more

August 14, 2021

Metformin

Read more

Subscribe to the email digest

Doctors and Researchers can receive a weekly summary of relevant research articles.